VIRX logo

Viracta Therapeutics (VIRX) Company Overview

Profile

Full Name:

Viracta Therapeutics, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

September 27, 2005

Indexes:

Not included

Description:

Viracta Therapeutics is a biotechnology company focused on developing innovative treatments for cancer. They specialize in therapies that target viral infections linked to cancer, aiming to improve patient outcomes and quality of life through advanced research and clinical trials.

Events Calendar

Earnings

Next earnings date:

Mar 14, 2025

Recent quarterly earnings:

Nov 13, 2024

Recent annual earnings:

Mar 7, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Feb 25, 2021

Analyst ratings

Recent major analysts updates

Dec 27, 24 Rodman & Renshaw
Neutral
Nov 14, 24 RBC Capital
Outperform
Aug 16, 24 Leerink Partners
Market Perform
Aug 15, 24 RBC Capital
Outperform
May 23, 24 Oppenheimer
Outperform
Apr 17, 24 Oppenheimer
Outperform
Apr 16, 24 HC Wainwright & Co.
Buy
Mar 12, 24 HC Wainwright & Co.
Buy
Jan 5, 24 HC Wainwright & Co.
Buy
Nov 10, 23 RBC Capital
Outperform

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Viracta Therapeutics?
  • Does Viracta Therapeutics pay dividends?
  • What sector is Viracta Therapeutics in?
  • What industry is Viracta Therapeutics in?
  • What country is Viracta Therapeutics based in?
  • When did Viracta Therapeutics go public?
  • Is Viracta Therapeutics in the S&P 500?
  • Is Viracta Therapeutics in the NASDAQ 100?
  • Is Viracta Therapeutics in the Dow Jones?
  • When was Viracta Therapeutics's last earnings report?
  • When does Viracta Therapeutics report earnings?
  • Should I buy Viracta Therapeutics stock now?

What is the ticker symbol for Viracta Therapeutics?

The ticker symbol for Viracta Therapeutics is NASDAQ:VIRX

Does Viracta Therapeutics pay dividends?

No, Viracta Therapeutics does not pay dividends

What sector is Viracta Therapeutics in?

Viracta Therapeutics is in the Healthcare sector

What industry is Viracta Therapeutics in?

Viracta Therapeutics is in the Biotechnology industry

What country is Viracta Therapeutics based in?

Viracta Therapeutics is headquartered in United States

When did Viracta Therapeutics go public?

Viracta Therapeutics's initial public offering (IPO) was on September 27, 2005

Is Viracta Therapeutics in the S&P 500?

No, Viracta Therapeutics is not included in the S&P 500 index

Is Viracta Therapeutics in the NASDAQ 100?

No, Viracta Therapeutics is not included in the NASDAQ 100 index

Is Viracta Therapeutics in the Dow Jones?

No, Viracta Therapeutics is not included in the Dow Jones index

When was Viracta Therapeutics's last earnings report?

Viracta Therapeutics's most recent earnings report was on Nov 13, 2024

When does Viracta Therapeutics report earnings?

The next expected earnings date for Viracta Therapeutics is Mar 14, 2025

Should I buy Viracta Therapeutics stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions